"Leukemia, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Descriptor ID |
D015458
|
| MeSH Number(s) |
C04.557.337.428.580 C15.604.515.560.575 C20.683.515.528.582
|
| Concept/Terms |
Leukemia, T-Cell- Leukemia, T-Cell
- Leukemia, T Cell
- Leukemia, Lymphocytic, T-Cell
- Lymphocytic Leukemia, T-Cell
- Leukemia, T-Cell Lymphocytic
- Leukemias, T-Cell Lymphocytic
- Lymphocytic Leukemia, T Cell
- Lymphocytic Leukemias, T-Cell
- T-Cell Lymphocytic Leukemia
- T-Cell Lymphocytic Leukemias
- T-Cell Leukemia
- Leukemias, T-Cell
- T Cell Leukemia
- T-Cell Leukemias
- T-Lymphocytic Leukemia
- Leukemia, T-Lymphocytic
- Leukemias, T-Lymphocytic
- T-Lymphocytic Leukemias
- Leukemia, Lymphocytic, T Cell
- T Lymphocytic Leukemia
- Leukemia, T Lymphocytic
- Leukemias, T Lymphocytic
- Lymphocytic Leukemia, T
- Lymphocytic Leukemias, T
- T Lymphocytic Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, T-Cell".
This graph shows the total number of publications written about "Leukemia, T-Cell" by people in this website by year, and whether "Leukemia, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, T-Cell" by people in Profiles.
-
Hillion J, Belton AM, Shah SN, Turkson J, Jing N, Tweardy DJ, di Cello F, Huso DL, Resar LM. Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia. Leuk Lymphoma. 2014 May; 55(5):1194-7.
-
Arakaki AK, Mezencev R, Bowen NJ, Huang Y, McDonald JF, Skolnick J. Identification of metabolites with anticancer properties by computational metabolomics. Mol Cancer. 2008 Jun 17; 7:57.
-
Chen S, Ishii N, Ine S, Ikeda S, Fujimura T, Ndhlovu LC, Soroosh P, Tada K, Harigae H, Kameoka J, Kasai N, Sasaki T, Sugamura K. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol. 2006 Feb; 18(2):269-77.
-
Ghoneum M, Gollapudi S. Modified arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis. Cancer Lett. 2003 Nov 10; 201(1):41-9.
-
Song KJ, Nerurkar VR, Pereira-Cortez AJ, Yamamoto M, Taguchi H, Miyoshi I, Yanagihara R. Sequence and phylogenetic analyses of human T cell lymphotropic virus type 1 from a Brazilian woman with adult T cell leukemia: comparison with virus strains from South America and the Caribbean basin. Am J Trop Med Hyg. 1995 Jan; 52(1):101-8.
-
Gee BE, Platt OS. Sickle reticulocytes adhere to VCAM-1. Blood. 1995 Jan 01; 85(1):268-74.
-
Sherman MP, Dube S, Spicer TP, Kane TD, Love JL, Saksena NK, Iannone R, Gibbs CJ, Yanagihara R, Dube DK, et al. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia. Cancer Res. 1993 Dec 15; 53(24):6067-73.